loading
Schlusskurs vom Vortag:
$14.77
Offen:
$14.72
24-Stunden-Volumen:
55,915
Relative Volume:
1.63
Marktkapitalisierung:
$2.53B
Einnahmen:
$603.63M
Nettoeinkommen (Verlust:
$468.71M
KGV:
5.4884
EPS:
2.682
Netto-Cashflow:
$-59.92M
1W Leistung:
+7.84%
1M Leistung:
+7.29%
6M Leistung:
-9.69%
1J Leistung:
-3.35%
1-Tages-Spanne:
Value
$14.67
$14.93
1-Wochen-Bereich:
Value
$13.20
$15.00
52-Wochen-Spanne:
Value
$11.51
$19.50

Hutchmed China Limited Adr Stock (HCM) Company Profile

Name
Firmenname
Hutchmed China Limited Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1,811
Name
Twitter
@hchimed
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
HCM's Discussions on Twitter

Vergleichen Sie HCM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
HCM
Hutchmed China Limited Adr
14.72 2.54B 603.63M 468.71M -59.92M 2.682
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
127.17 55.90B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
16.31 51.72B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.91 44.71B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
32.01 37.30B 16.88B 666.71M 251.19M 0.6132
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
45.79 20.48B 0 -5.87M -767.30K -0.45

Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-22 Herabstufung Morgan Stanley Equal-Weight → Underweight
2025-05-13 Herabstufung HSBC Securities Buy → Hold
2023-11-24 Hochstufung Deutsche Bank Hold → Buy
2022-05-04 Herabstufung Deutsche Bank Buy → Hold
2021-09-22 Herabstufung Goldman Buy → Neutral
2021-08-03 Eingeleitet Jefferies Buy
2020-10-02 Eingeleitet Deutsche Bank Buy
2020-03-13 Eingeleitet Cantor Fitzgerald Overweight
2020-02-20 Eingeleitet Goldman Buy
2019-11-19 Eingeleitet CLSA Buy
2019-10-23 Bestätigt BofA/Merrill Buy
2019-07-05 Eingeleitet Macquarie Outperform
Alle ansehen

Hutchmed China Limited Adr Aktie (HCM) Neueste Nachrichten

pulisher
Jan 08, 2026

Why HUTCHMED (China) Limited Depositary Receipt stock could see breakout soonJuly 2025 Intraday Action & Stepwise Trade Execution Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 07, 2026

Wall Street Analysts Predict a 55.93% Upside in HUTCHMED (HCM): Here's What You Should Know - Finviz

Jan 07, 2026
pulisher
Jan 07, 2026

HUTCHMED (NASDAQ:HCM) Trading 8.1% HigherHere's What Happened - MarketBeat

Jan 07, 2026
pulisher
Jan 07, 2026

HUTCHMED (China) Limited ADR (HCM) Stock Price Today | Live Chart & News - Traders Union

Jan 07, 2026
pulisher
Jan 06, 2026

HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China - GlobeNewswire Inc.

Jan 06, 2026
pulisher
Jan 02, 2026

HUTCHMED (LON:HCM) Share Price Passes Below 200-Day Moving Average – Here’s What Happened - Defense World

Jan 02, 2026
pulisher
Jan 02, 2026

HUTCHMED (NASDAQ:HCM) Sees Strong Trading Volume – Should You Buy? - Defense World

Jan 02, 2026
pulisher
Jan 01, 2026

MACD Signals Flash Warning for The Hindustan Housing Company Limited StockMarket Entry Points & Free Navigate Market With Precision - bollywoodhelpline.com

Jan 01, 2026
pulisher
Dec 31, 2025

HUTCHMED (NASDAQ:HCM) Sees Large Volume IncreaseShould You Buy? - MarketBeat

Dec 31, 2025
pulisher
Dec 29, 2025

[6-K] HUTCHMED (China) Ltd Current Report (Foreign Issuer) | HCM SEC FilingForm 6-K - Stock Titan

Dec 29, 2025
pulisher
Dec 29, 2025

REGHutchmed China LtdBlocklisting Six Monthly Return - TradingView — Track All Markets

Dec 29, 2025
pulisher
Dec 22, 2025

HUTCHMED (NASDAQ:HCM) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Dec 22, 2025
pulisher
Dec 20, 2025

Brokerages Set HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Target Price at $20.88 - Defense World

Dec 20, 2025
pulisher
Dec 17, 2025

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Dec 17, 2025
pulisher
Dec 16, 2025

HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors - GlobeNewswire

Dec 16, 2025
pulisher
Dec 05, 2025

Bearish block trade of HUTCHMED(00013) 278.5K shares at $22.0, $6.127M turnover - AASTOCKS.com

Dec 05, 2025
pulisher
Dec 03, 2025

Schroder Investment Management Group Has $38.82 Million Stock Holdings in HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat

Dec 03, 2025
pulisher
Nov 28, 2025

HUTCHMED Share Movement in the (LSE:HCM) Landscape and FTSE Aim 100 - Kalkine Media

Nov 28, 2025
pulisher
Nov 25, 2025

Forge Global Holdings, Inc. (NYSE:FRGE) Receives $42.00 Average Price Target from Analysts - Defense World

Nov 25, 2025
pulisher
Nov 25, 2025

Rep. Lisa C. McClain Sells Off Shares of Gartner, Inc. (NYSE:IT) - Defense World

Nov 25, 2025
pulisher
Nov 23, 2025

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Nov 23, 2025
pulisher
Nov 20, 2025

Catalyst Funds Management Pty Ltd Sells 29,903 Shares of HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat

Nov 20, 2025
pulisher
Nov 16, 2025

ABN Amro Investment Solutions Invests $962,000 in HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat

Nov 16, 2025
pulisher
Nov 14, 2025

HMPL-A251 combines HER2 targeting with precision payload - BioWorld MedTech

Nov 14, 2025
pulisher
Nov 05, 2025

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - The Globe and Mail

Nov 05, 2025
pulisher
Nov 04, 2025

Transcript : HUTCHMED Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025, Nov-04-2025 08 - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025Slideshow (NASDAQ:HCM) 2025-11-04 - Seeking Alpha

Nov 04, 2025
pulisher
Nov 04, 2025

Hutchmed Strengthens Position Within FTSE AIM 100 Index Healthcare Sphere - Kalkine Media

Nov 04, 2025
pulisher
Nov 04, 2025

HUTCHMED Announces Enrollment Completed of SAFFRON Global - GlobeNewswire

Nov 04, 2025
pulisher
Nov 03, 2025

Hutchmed takes wraps off expanding oncology pipeline - Sharecast.com

Nov 03, 2025
pulisher
Nov 03, 2025

Market news - investments.halifax.co.uk

Nov 03, 2025
pulisher
Nov 03, 2025

HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

RCSHutchmed China LtdUpdates from R&D Event - TradingView

Nov 03, 2025
pulisher
Nov 01, 2025

ETFs Investing in HUTCHMED (China) Limited Sponsored ADR Stocks - TradingView

Nov 01, 2025
pulisher
Oct 31, 2025

CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Manila Times

Oct 31, 2025
pulisher
Oct 31, 2025

About Us - FinancialContent

Oct 31, 2025
pulisher
Oct 30, 2025

International companies to host live webcasts at Deutsche - GlobeNewswire

Oct 30, 2025
pulisher
Oct 30, 2025

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - Yahoo Finance

Oct 30, 2025
pulisher
Oct 29, 2025

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Oct 29, 2025
pulisher
Oct 26, 2025

Vanguard Personalized Indexing Management LLC Buys 4,773 Shares of Cleanspark, Inc. $CLSK - Defense World

Oct 26, 2025
pulisher
Oct 26, 2025

Vanguard Personalized Indexing Management LLC Sells 354 Shares of Cathay General Bancorp $CATY - Defense World

Oct 26, 2025
pulisher
Oct 23, 2025

Hutchmed upbeat on preclinical data for novel cancer therapy - Sharecast.com

Oct 23, 2025
pulisher
Oct 23, 2025

HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - The Manila Times

Oct 23, 2025

Finanzdaten der Hutchmed China Limited Adr-Aktie (HCM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_specialty_generic RDY
$13.40
price up icon 0.37%
$23.47
price up icon 0.99%
$135.79
price up icon 0.16%
$12.76
price up icon 1.27%
$483.23
price down icon 1.55%
drug_manufacturers_specialty_generic RGC
$45.79
price up icon 10.55%
Kapitalisierung:     |  Volumen (24h):